In a randomized Belgian trial that was published in 2001 ... The following outcomes were improved significantly in the intensive-glucose-control phase compared with the baseline phase: fewer ...

ANSWER: Although there are no clear studies to inform us of the ideal blood sugar control (the A1C is a ... Studies like the ACCORD trial, which showed that a very low A1C goal of 6% led to ...

But it remains unclear whether cardiovascular and mortality risk associated with CAN is mitigated by intensive glycemic treatment. This secondary analysis included 7866 patients from the ACCORDION ...

Medscape News UK, April 24, 2025 1 in 4 Patients With Resistant T2D Have Hypercortisolism Nearly a quarter of patients with difficult-to-control type 2 diabetes have hypercortisolism, with even ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

In a study published in eClinicalMedicine, researchers at the German Diabetes Center (DDZ) show that automated insulin ...

American pharmaceutical company Eli Lilly and Company this week announced results from a late-stage clinical trial for its oral ... safety and tolerability, glucose control, and weight loss ...

An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type ...

Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics ...